CAS No.: 1421373-62-7
Mutant EGFR inhibitor Catalog No. CSN17827
Synonyms: MDK-3627
Mutant EGFR inhibitor is a selective and potent Mutated EGFR inhibitor (L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant).
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT02139579 Lung, Carcinoma Phase 2 Unknown - - NCT02770014 Epidermal Growth Factor Recept... more >>or Non-Small Cell Lung Cancer Collapse << Phase 2 Active, not recruiting November 2023 United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Collapse << NCT02535338 EGFR Activating Mutation ... more >> EGFR Exon 20 Insertion Mutation Recurrent Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer AJCC v7 Collapse << Phase 1 Phase 2 Active, not recruiting - United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 Los Angeles County-USC Medical Center Los Angeles, California, United States, 90033 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Keck Medical Center of USC Pasadena Pasadena, California, United States, 91105 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 City of Hope South Pasadena South Pasadena, California, United States, 91030 Collapse << - 更多
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 1421373-62-7 | 储存条件 |
|
|
| 分子式 | C27H30ClN7O2 | 运输 | 蓝冰 | |
| 分子量 | 520.03 | 别名 | MDK-3627 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
|---|
| NCT02139579 | Lung, Carcinoma | Phase 2 | Unknown | - | - |
| NCT02770014 | Epidermal Growth Factor Recept... more >>or Non-Small Cell Lung Cancer Collapse << | Phase 2 | Active, not recruiting | November 2023 | United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Collapse << |
| NCT02535338 | EGFR Activating Mutation ... more >> EGFR Exon 20 Insertion Mutation Recurrent Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer AJCC v7 Collapse << | Phase 1 Phase 2 | Active, not recruiting | - | United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 Los Angeles County-USC Medical Center Los Angeles, California, United States, 90033 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Keck Medical Center of USC Pasadena Pasadena, California, United States, 91105 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 City of Hope South Pasadena South Pasadena, California, United States, 91030 Collapse << |
| NCT03667820 | Non-small Cell Lung Cancer (NS... more >>CLC) Collapse << | Phase 2 | Not yet recruiting | April 1, 2022 | - |
| NCT01189435 | Lung Cancer | Phase 2 | Terminated(Lack of accrual) | - | United States, New York ... more >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Collapse << |
| NCT01189435 | - | - | Terminated(Lack of accrual) | - | - |
| NCT02064491 | Non-small Cell Lung Cancer | Phase 2 | Completed | - | Finland ... more >> Helsinki University Hospital Espoo, Finland Helsinki University Hospital Helsinki, Finland Oulu University Hospital Oulu, Finland Pori Central Hospital Pori, Finland Tampere University Hospital Tampere, Finland Turku University Hopital Turku, Finland Vaasa Central Hospital Vaasa, Finland Collapse << |
| NCT00996892 | Solid Tumors | Phase 1 | Terminated(A recommended Phase... more >> 2 dose and schedule was not identified and the study was terminated before initiation of Stage 2B.) Collapse << | - | United States, Maryland ... more >> Baltimore, Maryland, United States, 21231 United States, Massachusetts Boston, Massachusetts, United States, 02114 Boston, Massachusetts, United States, 02215 United States, Michigan Detroit, Michigan, United States, 48201 United States, Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Nashville, Tennessee, United States, 37203 Collapse << |
| NCT03333343 | EGFR-mutant Non-small Cell Lun... more >>g Cancer Collapse << | Phase 1 | Recruiting | May 21, 2021 | Canada, Ontario ... more >> Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Germany Novartis Investigative Site Recruiting Koeln, Germany, 50937 Italy Novartis Investigative Site Recruiting Ancona, AN, Italy, 60126 Novartis Investigative Site Recruiting Milano, MI, Italy, 20162 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Taiwan Novartis Investigative Site Recruiting Tainan, Taiwan, 70421 Novartis Investigative Site Recruiting Taipei, Taiwan, 10002 Collapse << |
| NCT01967095 | EGFR-Mutant Lung Cancer | Phase 1 | Completed | - | United States, New Jersey ... more >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Rockville Centre Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center at Phelps Sleepy Hollow, New York, United States, 10591 Collapse << |
| NCT02340221 | Breast Cancer | Phase 3 | Active, not recruiting | July 3, 2021 | - |
| NCT01229150 | Non Small Cell Lung Carcinoma | Phase 2 | Completed | - | United States, California ... more >> University of California, Davis Davis, California, United States, 95616 University of Southern California Health Sciences Campus Los Angeles, California, United States, 90033 City of Hope Medical Group South Pasadena, California, United States, 91030 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
| NCT03153358 | Lung Cancer Stage IV | Phase 2 | Not yet recruiting | May 2, 2019 | - |
| NCT01229150 | - | - | Completed | - | - |
| NCT01833572 | Non-small-cell Lung Cancer | Phase 2 | Unknown | - | China ... more >> Fudan University Shanghai Cancer Center Recruiting Shanghai, China, 200032 Contact: Haiquan Chen, MD +86-21 64175590 ext 1707 hqchen1@yahoo.com Principal Investigator: Haiquan Chen, MD Collapse << |
| NCT01859026 | Lung Cancer N... more >>on-Small Cell Lung Cancer Collapse << | Phase 1 | Recruiting | March 31, 2020 | United States, Florida ... more >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Germaine Gonzalez-Vazquez 813-745-6636 germaine.gonzalezvazquez@moffitt.org Sub-Investigator: Scott Antonia, M.D. Sub-Investigator: Eric Haura, M.D. Sub-Investigator: Charles Williams, M.D. Principal Investigator: Jhanelle Gray, M.D. Sub-Investigator: Tawee Tanvetyanon, M.D. Collapse << |
| NCT00996892 | - | - | Terminated(A recommended Phase... more >> 2 dose and schedule was not identified and the study was terminated before initiation of Stage 2B.) Collapse << | - | - |
| NCT03074864 | Non-small Cell Lung Cancer ... more >> Epidermal Growth Factor Receptor Collapse << | Phase 2 Phase 3 | Active, not recruiting | June 30, 2020 | China, Guangdong ... more >> Guangdong General Hospital Guangzhou, Guangdong, China, 510080 Collapse << |
| NCT02893332 | Stage IV EGFR Mutated Non-Smal... more >>l Cell Lung Cancer Collapse << | Phase 3 | Recruiting | December 2020 | China, Sichuan ... more >> Sichuan PPH, Cancer Center Recruiting Chengdu, Sichuan, China, 710062 Contact: Ming Zeng, MD PhD 008617708131336 miller2002@yahoo.com Contact: Ruilian Yu, MD 008617708130619 19986720@qq.com Collapse << |
| NCT01124864 | Non-small-cell Lung Cancer | Phase 2 | Completed | - | United States, California ... more >> University of California at Los Angeles UCLA - Santa Monica Los Angeles, California, United States, 90095 United States, Maryland Maryland Oncology Hematology, P.A. Dept. of Assoc. Onc/Hem Rockville, Maryland, United States, 20850 United States, Massachusetts Dana Farber Cancer Institute DFCI Boston, Massachusetts, United States, 02215 United States, Pennsylvania St. Luke's Hospital and Health Network St Luke's Bethlehem, Pennsylvania, United States Canada, Alberta Novartis Investigative Site Edmonton, Alberta, Canada, T6G 1Z2 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3T 1E2 France Novartis Investigative Site Creteil, France, 94000 Novartis Investigative Site Marseille cedex 20, France, 13915 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Oldenburg, Germany, 26121 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 137-701 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1081 HV Novartis Investigative Site Groningen, Netherlands, 9713 GZ Norway Novartis Investigative Site Oslo, Norway, NO-0379 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Spain Novartis Investigative Site Badalona, Catalunya, Spain, 08916 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Turkey Novartis Investigative Site Izmir, Turkey, 35040 Collapse << |
| NCT01124864 | - | - | Completed | - | - |
| NCT02886195 | EGFR Gene Mutation | Phase 3 | Enrolling by invitation | July 2019 | - |
| NCT01866410 | Recurrent Non-Small Cell Lung ... more >>Carcinoma Stage IV Non-Small Cell Lung Cancer AJCC v7 Collapse << | Phase 2 | Completed | - | United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 City of Hope South Pasadena South Pasadena, California, United States, 91030 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 Collapse << |
| NCT03450330 | Nonsmall Cell Lung Cancer | Phase 1 Phase 2 | Recruiting | July 2022 | Australia, Victoria ... more >> Austin Hospital Recruiting Heidelberg, Victoria, Australia, 3084 Contact: Sarah Healy Principal Investigator: Tom John Australia Northern Cancer Institute St Leonards Active, not recruiting Sydney, Australia, 2066 Collapse << |
| NCT01719380 | Colorectal Cancer | Phase 1 Phase 2 | Active, not recruiting | July 31, 2019 | - |
| NCT03050437 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Recruiting | March 2017 | Korea, Republic of ... more >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Myung-Ju Ahn, Ph.D. 822-3410-1795 silkahn@skku.edu Collapse << |
| NCT01838577 | - | - | Active, not recruiting | October 2019 | United Kingdom ... more >> Royal Marsden Sutton, United Kingdom Collapse << |
| NCT02431169 | - | - | Recruiting | May 31, 2020 | United States, Missouri ... more >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Daniel Morgensztern, M.D. 314-362-5737 danielmorgensztern@wustl.edu Contact: Kristi Williams, B.S. 314 362-6963 kjw1@wustl.edu Sub-Investigator: Ramaswamy Govindan, M.D. Sub-Investigator: Danielle Carpenter, M.D. Sub-Investigator: Elaine Mardis, Ph.D. Sub-Investigator: Saiama Waqar, M.D. Sub-Investigator: Maria Baggstrom, M.D Sub-Investigator: Ashiq Masood, M.D. Sub-Investigator: Michael Naughton, M.D. Sub-Investigator: Peter Oppelt, M.D. Sub-Investigator: Caron Rigden, M.D. Collapse << |
| NCT02274337 | Non-Small Cell Lung Cancer | Phase 1 Phase 2 | Unknown | December 2017 | China, Guangdong ... more >> Sun Yat-Sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Yuxiang Ma, MD 86-020-87343894 mayx@sysucc.org.cn Collapse << |
| NCT00326495 | Metastatic Colorectal Cancer | Phase 2 | Completed | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
| NCT03257124 | Non-Small Cell Lung Cancer Wit... more >>h EGFR T790M Mutation With Brain and/or Leptomeningeal Metastasis Failed Tyrosine Kinase Inhibitors Collapse << | Phase 2 | Recruiting | December 31, 2019 | Korea, Republic of ... more >> Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine Recruiting Seoul, Korea, Republic of, 135-710 Contact: Myung-Ju Ahn, M.D. +82-2-3410-3438 silk.ahn@samsung.com Collapse << |
| NCT02349633 | Non-Small Cell Lung Cancer | Phase 2 | Active, not recruiting | March 15, 2020 | United States, California ... more >> UC San Diego Moores Cancer Center - Investigational Drug Services La Jolla, California, United States, 92037-0845 UC San Diego Medical Center - La Jolla La Jolla, California, United States, 92037 UC San Diego Moores Cancer Center La Jolla, California, United States, 92093-0698 UC San Diego Medical Center - Hillcrest San Diego, California, United States, 92103 United States, Connecticut Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States, 06510 United States, Pennsylvania Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 UPMC Cancer Pavilion Pittsburgh, Pennsylvania, United States, 15232 UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 Australia, New South Wales Chris O'Brien Lifehouse Camperdown, New South Wales, Australia, 2050 Royal Prince Alfred Hospital Camperdown, New South Wales, Australia, 2050 Australia, Queensland Prince Charles Hospital, Cancer Care Services Chermside, Queensland, Australia, 4032 Japan National Hospital Organization Shikoku Cancer Center Matsuyama, Ehime, Japan, 791-0280 The Cancer Institute Hospital of JFCR Koto-ku, Tokyo, Japan, 135-8550 Korea, Republic of Seoul National University Hospital / Department of Internal Medicine Seoul, Korea, Republic of, 03080 Severance Hospital, Yonsei University Health System Seoul, Korea, Republic of, 03722 Asan Medical Center Seoul, Korea, Republic of, 05505 Clinical Trial Pharmacy Seoul, Korea, Republic of, 05505 Collapse << |
| NCT00326495 | - | - | Completed | - | - |
| NCT01219543 | Solid Tumour ... more >>Advanced Solid Malignancies Child-Pugh A to B7 Advanced Hepatocellular Carcinoma EGFR and/or ROS Mutant NSCLC Lung Metastasis Carcinoma Gastric Cancer Collapse << | Phase 1 | Terminated(Compound developmen... more >>t discontinued) Collapse << | - | Korea, Republic of ... more >> Research Site Seoul, Korea, Republic of Collapse << |
| NCT01553942 | Lung Cancer | Phase 2 | Recruiting | December 2020 | United States, Massachusetts ... more >> Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Geoffrey Oxnard, MD 617-632-6049 goxnard@partners.org Principal Investigator: Geoffrey Oxnard, MD Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Lecia V Sequist, MD MPH 617-724-4000 lvsequist@partners.org Principal Investigator: Lecia V Sequist, MD MPH Collapse << |
| NCT03433469 | EGFR (Epidermal Growth Factor ... more >>Receptor) Exon 19 Deletion Mutation EGFR NP_005219.2:p.L858R EGFR NP_005219.2:p.T790M Stage I Non-Small Cell Lung Cancer AJCC (American Joint Committee on Cancer) v7 Stage IA Non-Small Cell Lung Carcinoma AJCC v7 Stage IB Non-Small Cell Lung Carcinoma AJCC v7 Stage II Non-Small Cell Lung Cancer AJCC v7 Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Collapse << | Phase 2 | Recruiting | May 31, 2022 | United States, California ... more >> University of California, San Francisco Recruiting San Francisco, California, United States, 94115 Contact: Collin M. Blakely, M.D. 877-827-3222 cancertrials@ucsf.edu Principal Investigator: Collin M. Blakely, M.D. United States, Colorado University of Colorado Not yet recruiting Denver, Colorado, United States, 80217-3364 Contact: Robert C. Doebele 303-724-2980 robert.doebele@ucdenver.edu Principal Investigator: Robert C. Doebele Collapse << |
| NCT02630186 | Non-small Cell Lung Cancer | Phase 1 Phase 2 | Completed | - | United States, California ... more >> University of California at Los Angeles Santa Monica, California, United States, 90404 Collapse << |
| NCT03292133 | Lung Cancer | Phase 2 | Recruiting | March 31, 2025 | United States, Massachusetts ... more >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02214 Contact: Beth Kennedy 617-724-1223 EAKENNEDY@mgh.harvard.edu Principal Investigator: Zofia Piotrowska, MD Collapse << |
| NCT02926768 | Lung Neoplasms ... more >> Carcinoma, Non-Small-Cell Lung Neoplasms Lung Diseases Adenocarcinoma Advanced Solid Tumors Collapse << | Phase 1 Phase 2 | Recruiting | December 2020 | United States, Florida ... more >> Research Site Recruiting Sarasota, Florida, United States, 34232 United States, Missouri Research Site Recruiting Saint Louis, Missouri, United States, 63110 United States, New Jersey Research Site Recruiting Hackensack, New Jersey, United States, 07601 United States, Tennessee Research Site Recruiting Nashville, Tennessee, United States, 37203 Australia, Queensland Research Site Recruiting Greenslopes, Queensland, Australia, 4120 New Zealand Research Site Recruiting Grafton, Auckland, New Zealand, 1010 Research Site Recruiting Christchurch, New Zealand, 8011 Research Site Recruiting Wellington, New Zealand, 6021 Poland Research Site Recruiting Bydgoszcz, Kujawsko-Pomorskie, Poland, 85-231 Research Site Recruiting Bydgoszcz, Kujawsko-Pomorskie, Poland, 85-796 Research Site Recruiting Lublin, Lubelskie, Poland, 20-064 Research Site Recruiting Białystok, Podlaskie, Poland, 15-044 Research Site Recruiting Poznań, Wielkopolskie, Poland, 60-693 Research Site Recruiting Szczecin, Zachodniopomorskie, Poland, 70-784 Thailand Research Site, Pathumwan Recruiting Bangkok, Thailand, 10330 Research Site, Ratchathewi District Recruiting Bangkok, Thailand, 10400 Research Site, Bangkok Noi District Recruiting Bangkok, Thailand, 10700 Research Site, Muang District Recruiting Chiang Mai, Thailand, 50200 Research Site Recruiting Khon Kaen, Thailand, 40002 Research Site, Muang Recruiting Phitsanulok, Thailand, 65000 Collapse << |
| NCT02297425 | Advanced EGFRm (Del 19 or L858... more >>R +/- T790M) NSCLC Collapse << | Phase 2 | Withdrawn | March 2018 | - |
| NCT01724801 | Brain Metastasis ... more >> Non Small Cell Lung Cancer Collapse << | Phase 3 | Completed | - | China, Guangdong ... more >> Guangdong General Hospital Guangzhou, Guangdong, China, 510080 Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences Guangzhou, Guangdong, China, 510080 Collapse << |
| NCT02151721 | Non-Small-Cell Lung Carcinoma | Phase 1 | Active, not recruiting | February 20, 2018 | Japan ... more >> Nagoya University Graduate School of Medicine Nagoya, Aichi, Japan, 466-8560 Institute of Biomedical Research and Innovation Hospital Kobe, Hyogo-ken, Japan, 650-0047 Kanazawa University Hospital Kanazawa, Ishikawa, Japan, 920-0934 Tohoku University Hospital Sendai, Miyagi, Japan, 980-8574 Shizuoka Cancer Center Sunto-gun, Shizuoka, Japan, 411-8777 Collapse << |
| NCT01573702 | Non Small Cell Lung Cancer | Phase 2 | Active, not recruiting | May 2019 | United States, California ... more >> University of California at San Francisco San Francisco, California, United States, 94115 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, North Carolina Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 East Carolina University Greenville, North Carolina, United States, 27834 United States, Ohio STO Taussig Cancer Center; Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98104 Collapse << |
| NCT03755102 | EGFR Gene Mutation ... more >> Lung Cancer Lung Cancer Metastatic Collapse << | Early Phase 1 | Recruiting | November 2019 | United States, New Jersey ... more >> Memoral Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Helen Yu, MD 646-888-4274 Memoral Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Helen Yu, MD 646-888-4274 United States, New York Memorial Sloan Kettering Cancer Center @ Commack Recruiting Commack, New York, United States, 11725 Contact: Helen Yu, MD 646-888-4274 Memoral Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Helen Yu, MD 646-888-4274 Memorial Sloan - Kettering Cancer Center Recruiting New York, New York, United States, 10021 Contact: Helen Yu, MD 646-888-4274 Memorial Sloan Kettering @ Rockville Recruiting Rockville Centre, New York, United States, 11570 Contact: Helen Tu, MD 646-888-4274 Collapse << |
| NCT02906163 | EGFR Mutation Positive Non Sma... more >>ll Cell Lung Cancer Collapse << | Phase 1 Phase 2 | Not yet recruiting | January 2020 | Italy ... more >> Azienda Sanitaria Locale Frosinone Not yet recruiting Frosinone, Italy Contact: Dott.ssa Teresa Gamucci Principal Investigator: Dott.ssa Teresa Gamucci Istituto Nazionale dei Tumori Not yet recruiting Milan, Italy Contact: Dott.ssa Marina Chiara Garassino Principal Investigator: Dott.ssa Marina Chiara Garassino Roma_Campus Bio-Medico Not yet recruiting Rome, Italy Contact: Prof. Daniele Santini Principal Investigator: Prof. Daniele Santini Sant'Andrea Hospital Not yet recruiting Rome, Italy Contact: Prof. Paolo Marchetti Principal Investigator: Prof. Paolo Marchetti Presidio Sanitario San Camillo Not yet recruiting Torino, Italy Contact: Dott.ssa Maria Rita Migliorino Principal Investigator: Dott.ssa Maria Rita Migliorino Collapse << |
| NCT02851329 | - | - | Enrolling by invitation | July 2017 | China, Beijing ... more >> Key Laboratory of Molecular Imaging, Chinese Academy of Sciences Beijing, Beijing, China, 100190 Collapse << |
| NCT03543683 | Non-Small Cell Lung Cancer Sta... more >>ge IIIB Non-small Cell Lung Cancer Stage IV EGFR T790M Collapse << | Phase 2 | Not yet recruiting | June 30, 2021 | - |
| NCT02520778 | EGFR Activating Mutation ... more >> EGFR Exon 19 Deletion Mutation EGFR NP_005219.2:p.G719X EGFR NP_005219.2:p.L858R EGFR NP_005219.2:p.L861Q EGFR NP_005219.2:p.T790M Stage III Non-Small Cell Lung Cancer AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Stage IV Non-Small Cell Lung Cancer AJCC v7 Collapse << | Phase 1 | Recruiting | - | United States, California ... more >> University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact 916-734-3089 Principal Investigator: Jonathan W. Riess United States, Colorado University of Colorado Hospital Active, not recruiting Aurora, Colorado, United States, 80045 United States, Florida Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Site Public Contact 800-456-7121 canceranswers@moffitt.org Principal Investigator: Eric B. Haura United States, Georgia Emory University Hospital/Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Site Public Contact 404-778-1868 Principal Investigator: Suchita Pakkala United States, Kentucky University of Kentucky/Markey Cancer Center Active, not recruiting Lexington, Kentucky, United States, 40536 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Site Public Contact 410-955-8804 jhcccro@jhmi.edu Principal Investigator: Christine L. Hann United States, Massachusetts Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Site Public Contact 877-726-5130 Principal Investigator: Geoffrey R. Oxnard Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Site Public Contact 877-442-3324 Principal Investigator: Geoffrey R. Oxnard United States, New Jersey Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Site Public Contact 732-235-8675 Principal Investigator: Jyoti Malhotra Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Site Public Contact 732-235-8675 Principal Investigator: Jyoti Malhotra United States, North Carolina UNC Lineberger Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Site Public Contact 877-668-0683 cancerclinicaltrials@med.unc.edu Principal Investigator: Jared M. Weiss Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Site Public Contact 888-275-3853 Principal Investigator: James L. Abbruzzese United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Site Public Contact 800-293-5066 Jamesline@osumc.edu Principal Investigator: Erin M. Bertino United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Site Public Contact 412-647-8073 Principal Investigator: Liza C. Villaruz United States, Virginia University of Virginia Cancer Center Recruiting Charlottesville, Virginia, United States, 22908 Contact: Site Public Contact 434-243-6303 PAS9E@virginia.edu Principal Investigator: Ryan D. Gentzler Collapse << |
| NCT01755923 | Non-small Cell Lung Cancer | Phase 2 | Unknown | December 2014 | China, Beijing ... more >> Department of Respiratory Medicine, Peking Union Medical College Hospita Recruiting Beijing, Beijing, China, 100730 Contact: Mengzhao Wang, MD 010-69155039 ext +86 mengzhaowang@sina.com Contact: Jing Zhao, MD 010-69158206 ext +86 pumchzj@sina.com Sub-Investigator: Wei Zhong, MD Sub-Investigator: Jinmei Luo, MD Collapse << |
| NCT03424759 | Non Small Cell Lung Cancer | Phase 2 | Active, not recruiting | July 31, 2019 | Korea, Republic of ... more >> Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul, Korea, Republic of, 135-710 Collapse << |
| NCT02847377 | Carcinoma, Non-Small-Cell Lung | Early Phase 1 | Recruiting | March 27, 2019 | France ... more >> CGFL Recruiting Dijon, France, 21079 Collapse << |
| NCT03046992 | EGFR Gene Mutation | Phase 1 Phase 2 | Recruiting | April 2020 | Korea, Republic of ... more >> Severance Hospital Recruiting Seoul, Korea, Republic of Contact: Byoung Chul Cho, MD.,PhD Collapse << |
| NCT01928160 | Recurrent Non-small Cell Lung ... more >>Cancer Stage IV Non-small Cell Lung Cancer Collapse << | Phase 2 | Withdrawn(study not accruing) | - | - |
| NCT03455829 | Carcinoma, Non-Small-Cell Lung... more >> Lung Cancer Non-small Cell Lung Cancer Collapse << | Phase 1 Phase 2 | Recruiting | April 2023 | United States, California ... more >> Beverly Hills Cancer Center Recruiting Beverly Hills, California, United States, 90211 Principal Investigator: David Berz, MD St Joseph Heritage Healthcare Recruiting Santa Rosa, California, United States, 95403 Contact: Ian Anderson, MD Collapse << |
| NCT00874419 | Non-small Cell Lung Cancer | Phase 3 | Completed | - | China ... more >> Medical Department, Shanghai Pulmonary Hospital Shanghai, China, 200433 Collapse << |
| NCT02186301 | Non-Small Cell Lung Cancer | Phase 2 Phase 3 | Terminated(Sponsor discontinue... more >>d development of CO-1686 for NSCLC) Collapse << | - | - |
| NCT01904916 | Solid Tumors ... more >>Metastatic Disease Collapse << | Not Applicable | Terminated | - | Netherlands ... more >> Antoni van Leeuwenhoek Ziekenhuis Amsterdam, Netherlands Erasmus Medical Center Rotterdam, Netherlands University Medical Center Utrecht Utrecht, Netherlands, 3508 GX Collapse << |
| NCT02330367 | Metastatic Non-small Cell Lung... more >> Cancer Collapse << | Phase 1 | Recruiting | December 2019 | China, Beijing ... more >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100000 Contact: Tongtong An Cancer Institute Hospital,Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100000 Contact: Junling Li Chinese General PLA Hospital Recruiting Beijing, Beijing, China, 100000 Contact: Hong Zhao Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100000 Contact: Li Zhang The 307th Hospital of Military Chinese People's Liberation Army Recruiting Beijing, Beijing, China, 100000 Contact: Xiaoqing Liu China, Fujian Fujian Medical University Union Hospital Recruiting Fuzhou, Fujian, China, 350000 Contact: Xiaoyan Lin China, Guangdong Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510000 Contact: Li Zhang Guangdong People's Hospital Recruiting Guangzhou, Guangdong, China Contact: Qing Zhou, MD. Principal Investigator: Yilong Wu, Professor China, Hunan Hunan Cancer Hospital Recruiting Changsha, Hunan, China, 410000 Contact: Lin Wu Contact: Nong Yang China, Jiangsu Jiangsu Cancer Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Jifeng Feng Jiangsu Province Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Yongqian Shu Nanjing General Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Yong Song China, Jilin Jilin Tumor Hospital Recruiting Chang Chun, Jilin, China, 130000 Contact: Ying Cheng China, Shanghai Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China, 200000 Contact: Baohui Han China, Sichuan West China Hospital,Sichuan University Recruiting Chendu, Sichuan, China, 610000 Contact: Feng Luo China, Zhejiang The First Affiliated Hospital of Zhejiang University School of Medicine Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Jianying Zhou The Second Affiliated Hospital of Zhejiang University School of Medicine Recruiting Hanzhou, Zhejiang, China, 310000 Contact: Kai Wang Collapse << |
| NCT01257594 | Brain Cancer | Not Applicable | Unknown | December 2016 | United States, New Jersey ... more >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States, 11725 Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Collapse << |
| NCT01854034 | Non Small Cell Lung Cancer | Phase 2 | Completed | - | United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Collapse << |
| NCT02879994 | Stage IIIA Non-Small Cell Lung... more >> Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Collapse << | Phase 2 | Active, not recruiting | July 2020 | United States, California ... more >> UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 Collapse << |
| NCT01927341 | Metastatic Colorectal Cancer | Phase 1 Phase 2 | Completed | - | United States, California ... more >> University of California at Los Angeles Dept of Onc Los Angeles, California, United States, 90095 United States, New York Memorial Sloan Kettering Cancer Center Oncology Dept NY, New York, United States, 90033 Belgium Array BioPharma Investigative Site Leuven, Belgium, 3000 Canada, Ontario Array BioPharma Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Array BioPharma Investigative Site Toulouse Cedex 9, France, 31059 Italy Array BioPharma Investigative Site Milano, MI, Italy, 20162 Netherlands Array BioPharma Investigative Site Amsterdam, Netherlands, 1066 CX Spain Array BioPharma Investigative Site Barcelona, Catalunya, Spain, 08035 Collapse << |
| NCT01854034 | - | - | Completed | - | - |
| NCT01337765 | Unspecified Adult Solid Tumor,... more >> Protocol Specific Solid Tumor Collapse << | Phase 1 | Completed | - | United States, Massachusetts ... more >> Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States, 02114 United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson PSC Houston, Texas, United States, 77030-4009 Australia, Victoria Novartis Investigative Site Parkville, Victoria, Australia, 3050 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Villejuif Cedex, France, 94805 Spain Novartis Investigative Site Barcelona, Cataluña, Spain, 08035 Collapse << |
| NCT00784667 | Metastatic Colorectal Cancer | Phase 2 | Unknown | February 2011 | Australia, New South Wales ... more >> Royal North Shore Hospital Sydney, New South Wales, Australia Australia, South Australia Queen Elizabeth Hospital Adelaide, South Australia, Australia Australia, Victoria Ballarat Base Hospital Ballarat, Victoria, Australia Austin Health Melbourne, Victoria, Australia, 3084 Collapse << |
| NCT02147990 | Non-small Cell Lung Cancer | Phase 2 | Active, not recruiting | August 31, 2019 | - |
| NCT03091491 | Non-Small Cell Lung Cancer | Phase 2 | Recruiting | June 2020 | Singapore ... more >> National University Hospital Not yet recruiting Singapore, Singapore, 119074 Principal Investigator: Ross Soo National Cancer Centre Singapore Recruiting Singapore, Singapore, 169610 Principal Investigator: Eng Huat Tan Tan Tock Seng Hospital Not yet recruiting Singapore, Singapore Principal Investigator: Lavina Bharwani Collapse << |
| NCT02954523 | EGFR Gene Mutation ... more >> Nonsmall Cell Lung Cancer Collapse << | Phase 1 Phase 2 | Recruiting | November 2021 | United States, District of Col... more >>umbia Georgetown Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Jeanette Crawford, RN 202-687-0893 crawfojg@georgetown.edu Contact: Tisdrey Torres, RN 202-687-9861 tt665@georgetown.edu Principal Investigator: Giuseppe Giaccone, MD PhD Sub-Investigator: Chul Kim, MD United States, New Jersey John Theurer Cacner Center at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Allison Abate 551-996-0233 alison.abate@hackensackmeridian.org Principal Investigator: Martin Gutierrez, MD Collapse << |
| NCT01652833 | - | - | Completed | - | - |
| NCT02448251 | Non Small Cell Lung Cancer | Phase 1 | Recruiting | September 2019 | United States, California ... more >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Stanford University Recruiting Palo Alto, California, United States, 94304 United States, Georgia Emory University School of Medicine Recruiting Atlanta, Georgia, United States, 30322 United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 France CEPCM - Hopital Timone Recruiting Marseille, France, 13005 Spain START-Madrid-FJD Recruiting Madrid, Spain, 28040 START-Madrid-CIOCC Recruiting Madrid, Spain, 28050 Collapse << |
| NCT02040064 | Non Small Cell Lung Cancer | Phase 1 | Completed | - | France ... more >> Gustave Roussy Villejuif, Val de Marne, France, 94805 Collapse << |
| NCT01363232 | Advanced Solid Tumors ... more >> Selected Solid Tumors Collapse << | Phase 1 | Completed | - | United States, Massachusetts ... more >> Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States, 02115 United States, Michigan Karmanos Cancer Institute Study Coordinator Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan Kettering Cancer Center MSKCC (2) New York, New York, United States, 90033 United States, South Carolina Cancer Centers of the Carolinas CCC Faris Greenville, South Carolina, United States, 29605 United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson PSC Houston, Texas, United States, 77030-4009 Canada, Ontario Array BioPharma Investigative Site Toronto, Ontario, Canada, M5G 2M9 Germany Array BioPharma Investigative Site Essen, Germany, 45147 Array BioPharma Investigative Site Heidelberg, Germany, 69120 Netherlands Array BioPharma Investigative Site Utrecht, Netherlands, 3584CX Singapore Array BioPharma Investigative Site Singapore, Singapore, 169610 Spain Array BioPharma Investigative Site Barcelona, Catalunya, Spain, 08035 Switzerland Array BioPharma Investigative Site Bellinzona, Switzerland, 6500 Collapse << |
| NCT02342353 | Non-Small Cell Lung Cancer ... more >> Nonsmall Cell Lung Cancer Carcinoma, Non-Small-Cell Lung Collapse << | Phase 1 | Terminated(Drug shortage) | - | United States, Missouri ... more >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Collapse << |
| NCT01526928 | Locally Advanced or Metastatic... more >> Non Small Cell Lung Cancer Collapse << | Phase 1 Phase 2 | Active, not recruiting | August 31, 2019 | - |
| NCT00897663 | - | - | Completed | - | United States, Arizona ... more >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Iowa Siouxland Hematology-Oncology Associates, LLP Sioux City, Iowa, United States, 51101 Mercy Medical Center - Sioux City Sioux City, Iowa, United States, 51102 St. Luke's Regional Medical Center Sioux City, Iowa, United States, 51104 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, North Dakota Medcenter One Hospital Cancer Care Center Bismarck, North Dakota, United States, 58501 Mid Dakota Clinic, PC Bismarck, North Dakota, United States, 58501 St. Alexius Medical Center Cancer Center Bismarck, North Dakota, United States, 58502 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57701 Collapse << |
| NCT03623750 | Carcinoma, Non-Small-Cell Lung | Phase 1 Phase 2 | Recruiting | June 2020 | Spain ... more >> Hospital Universitario Insular de Gran Canaria Not yet recruiting Palmas de Gran Canaria, Canarias, Spain Contact: Delvys Rodríguez, M.D. Principal Investigator: Delvys Rodríguez Instituto Oncológico Dr. Rosell Not yet recruiting Barcelona, Spain, 08028 Contact: Niki Karachaliou, M.D., Ph.D. Principal Investigator: Niki Karachaliou, M.D., Ph.D. Hospital Clínic Barcelona Not yet recruiting Barcelona, Spain Contact: Noemi Reguart, M.D. Principal Investigator: Noemi Reguart, M.D. Hospital Universitario Regional de Málaga Recruiting Málaga, Spain Contact: Manuel Cobo Principal Investigator: Manuel Cobo, M.D. Collapse << |
| NCT02454842 | Non-small Cell Lung Cancer ... more >> NSCLC Non-squamous NSCLC Collapse << | Phase 2 | Terminated(Lack of efficacy) | - | United States, California ... more >> University of Southern California-Norris Los Angeles, California, United States, 90033 St. Joseph Heritage Healthcare Santa Rosa, California, United States, 95403 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, District of Columbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Maryland Walter Reed National Military Medical Center Bethesda, Maryland, United States, 20889 United States, North Carolina University of North Carolina Lineberger Cancer Center Chapel Hill, North Carolina, United States, 27514 United States, Pennsylvania University of Pennsylvania-Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 United States, Tennessee Vanderbilt-Ingram Cancer Center (VICC) Nashville, Tennessee, United States, 37232 United States, Texas UT Southwestern Medical Center Dallas, Texas, United States, 75235 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98104 Australia, Victoria Peter MacCullum Melbourne, Victoria, Australia, 3002 Collapse << |
| NCT02704767 | Lung Cancer | Phase 2 | Not yet recruiting | December 2019 | - |
| NCT02191891 | Carcinoma, Non-Small-Cell Lung | Phase 1 | Completed | - | Japan ... more >> National Hospital Organization Kyushu Cancer Center Fukuoka, Fukuoka, Japan, 811-1395 Korea, Republic of Chungbuk National University Hospital Cheongju, Korea, Republic of, 361-771 Severance Hospital, Yonsei University Health System Seoul, Korea, Republic of, 120-752 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center Seoul, Korea, Republic of, 138-736 Singapore National Cancer Centre Singapore, Singapore, 169610 Taiwan Chang Gung Memorial Hospital Chiayi Chiayi, Taiwan, 613 Kaohsiung Chang Gung Memorial Hospital Kaohsiung, Taiwan, 83301 NCKUH Tainan, Taiwan, 704 National Taiwan University Hospital Taipei, Taiwan, 100 Collapse << |
| NCT02322281 | Non-small Cell Lung Cancer | Phase 3 | Terminated(Sponsor discontinue... more >>d development of CO-1686 for NSCLC) Collapse << | - | - |
| NCT02321293 | Lung Cancer | Phase 1 | Unknown | December 2016 | Canada, Quebec ... more >> Peter Brojge Lung Cancer Center, Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Victor Cohen, MD,CM, FRCPC 514-340-8222 ext 3878 vcohen@jgh.mcgill.ca Contact: Goulnar Kasymjanova, MD 514-340-8222 ext 4312 gkasymja@jgh.mcgill.ca Sub-Investigator: Khashayar Esfahani, MD Sub-Investigator: Arif Awan, MD Sub-Investigator: Thomas R Jagoe, MD Sub-Investigator: Jason S Agulnik, MD Sub-Investigator: David Small, MD Sub-Investigator: Carmela Pepe, MD Sub-Investigator: Lama Sakr, MD Sub-Investigator: Goulnar Kasymjanova, MD Collapse << |
| NCT03392246 | Non-small Cell Lung Cancer | Phase 2 | Recruiting | June 30, 2025 | United States, Massachusetts ... more >> Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02214 Contact: Zofia Piotrowska, MD zpiotrowska@partners.org Principal Investigator: Zofia Piotrowska, MD Beth Israel Deaconess Medical Center Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Daniel Costa, MD dbcosta@bidmc.harvard.edu Principal Investigator: Daniel Costa, MD Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Sarah E Clifford 617-632-5438 SarahE_Clifford@DFCI.HARVARD.EDU Principal Investigator: Pasi A Janne, MD Collapse << |
| NCT03586453 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Recruiting | March 1, 2023 | United States, Massachusetts ... more >> Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Pasi A. Jänne, MD, PhD 617-632-6036 Pasi_Janne@dfci.harvard.edu Contact: Sarah Clifford, MPH 6176325438 sarahe_clifford@dfci.harvard.edu Principal Investigator: Pasi Jänne, MD, PhD Collapse << |
| NCT03647956 | NSCLC Stage IIIB ... more >> NSCLC Stage IV EGFR Activating Mutation Collapse << | Phase 2 | Recruiting | April 3, 2020 | Hong Kong ... more >> Department of Clinical Oncology Recruiting Hong Kong, Hong Kong Principal Investigator: Tai-Chung Lam, FRCR Sub-Investigator: Chi-Leung Chiang, FRCR Sub-Investigator: Victor Ho-Fun Lee, MD Sub-Investigator: Tsz-Him So, MBBS Collapse << |
| NCT03122717 | Non-Small Cell Lung Cancer | Phase 1 | Recruiting | April 2023 | United States, Massachusetts ... more >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Daniel Costa, MD, PhD dbcosta@bidmc.harvard.edu Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Pasi Janne, MD, PhD 617-632-6036 Pasi_Janne@dfci.harvard.edu Principal Investigator: Pasi Janne, MD, PhD Collapse << |
| NCT02496663 | EGFR Exon 19 Deletion Mutation... more >> EGFR Exon 20 Insertion Mutation EGFR NP_005219.2:p.G719X EGFR NP_005219.2:p.L858R EGFR NP_005219.2:p.L861Q EGFR NP_005219.2:p.T790M EGFR T790M Mutation Negative Recurrent Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer AJCC v7 Collapse << | Phase 1 | Recruiting | - | United States, California ... more >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org Principal Investigator: Marianna Koczywas Stanford Cancer Institute Palo Alto Recruiting Palo Alto, California, United States, 94304 Contact: Site Public Contact 650-498-7061 ccto-office@stanford.edu Principal Investigator: Sukhmani K. Padda University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact 916-734-3089 Principal Investigator: Jonathan W. Riess United States, Colorado University of Colorado Hospital Recruiting Aurora, Colorado, United States, 80045 Contact: Site Public Contact 720-848-0650 Principal Investigator: Jose M. Pacheco United States, District of Columbia MedStar Georgetown University Hospital Recruiting Washington, District of Columbia, United States, 20007 Contact: Site Public Contact 202-444-2223 Principal Investigator: Stephen V. Liu United States, Massachusetts Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Site Public Contact 877-726-5130 Principal Investigator: Pasi A. Janne Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com Principal Investigator: Pasi A. Janne Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Site Public Contact 617-667-9925 Principal Investigator: Pasi A. Janne Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Site Public Contact 877-442-3324 Principal Investigator: Pasi A. Janne United States, North Carolina Duke Cancer Institute Cary Recruiting Cary, North Carolina, United States, 27518 Contact: Site Public Contact 919-781-7070 Principal Investigator: James L. Abbruzzese Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Site Public Contact 888-275-3853 Principal Investigator: James L. Abbruzzese Collapse << |
